Products and Technologies for Regenerative and Aesthetic Medicine
CollPlant is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing.
Its revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.
| Name | CollPlant |
|---|---|
| Slug | collplant |
| Former names | CollPlant Holdings Ltd |
| Type / kind | startup |
| Crunchbase ID | collplant |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7q_YkLDA |
| Status | active |
|---|---|
| Status reason | Public on NASDAQ on Dec 2010; |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Prof. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel |
| Total raised | $91.0M |
|---|---|
| Current stage | Mature |
| Market cap | $17.9M |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}